Netsere Tesfayohannes
Pain Medicine · Greenbelt, MDNPI 1255316972
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,811 of the $5,484 with a category attached, or 87.7%. It is spread thinly across 29 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,648, 4.0 times the $411 reported in 2019.
Across 169 payments — averaging $32.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertos Medical, Inc.$824
- Spinefrontier, Inc.$807
- Collegium Pharmaceutical, Inc.$627
- Nevro Corp.$625
- Abbott$582
- Si-bone, Inc.$318
- plus $2K from 23 others
What the payments were for
- Travel & lodging$67312%
- Food & beverage$4,81188%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertos Medical, Inc. | 12 | $824 |
| Spinefrontier, Inc. | 3 | $807 |
| Collegium Pharmaceutical, Inc. | 31 | $627 |
| Nevro Corp. | 19 | $625 |
| Abbott | 28 | $582 |
| Si-bone, Inc. | 3 | $318 |
| Boston Scientific | 10 | $193 |
| Spinal Simplicity, LLC | 2 | $168 |
| Curonix LLC | 6 | $162 |
| Biotronik NRO, Inc. | 8 | $157 |
| IBSA Pharma Inc. | 7 | $150 |
| Stryker | 1 | $141 |
| Scilex Pharmaceuticals Inc. | 7 | $123 |
| Globus Medical | 4 | $100 |
| Biodelivery Sciences International, Inc. | 6 | $80 |
| Fidia Pharma USA Inc. | 3 | $66 |
| Painteq LLC | 2 | $42 |
| Kaleo, Inc. | 2 | $39 |
| Medtronic(2 entities) | 3 | $36 |
| Daiichi Sankyo Inc. | 2 | $34 |
| Johnson & Johnson | 2 | $34 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $29 |
| Amgen | 1 | $28 |
| Almatica Pharma LLC | 1 | $25 |
| MDD US Operations, LLC | 1 | $22 |
| Electronic Waveform Lab, Inc. | 1 | $19 |
| Stimwave Technologies Incorporated | 1 | $17 |
| Valinor Pharma, LLC | 1 | $17 |
| Bioventus LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- mild Device Kit$809
- InSpan$807
- SIJFuse$807
- FacetFuse$807
- NanoFuse$807
- iFuse Implant$288
- HA MINUTEMAN G3-R$145
- Omnia$112
How this compares
$5,484 in reported general payments places this provider in the 70th percentile of 144 pain medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 565 | $15,010 |
| Lidocaine | 109 | $14,355 |
| OxycontinOxycodone Hcl | 25 | $7,957 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 32 | $7,655 |
| Diclofenac Sodium | 61 | $4,822 |
| Xtampza ErOxycodone Myristate | 13 | $4,683 |
| MovantikNaloxegol Oxalate | 11 | $3,971 |
| Gabapentin | 239 | $3,201 |
| Oxycodone Hcl | 243 | $3,090 |
| Naloxone Hcl | 50 | $2,742 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 131 | $2,707 |
| Duloxetine Hcl | 106 | $2,006 |
| Tramadol Hcl ErTramadol Hcl | 22 | $1,987 |
| Pregabalin | 118 | $1,951 |
| Morphine Sulfate ErMorphine Sulfate | 55 | $1,281 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $627 | $4,68313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 144 pain medicine providers in Maryland.
Other pain medicine in Greenbelt
- Reza GhorbaniGreenbelt$24K
- Haddis HagosGreenbelt$8K
- Vipul MangalOxon Hill$764K
- Randy DavisBaltimore$169K
- Paul ChristoBaltimore$137K
- Kunal SoodGermantown$70K
- Ali TurabiBethesda$47K
- Behnam JafarpourBaltimore$45K
- Eric FinkelsteinOwings Mills$37K
- Ankush JainBethesda$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.